Salka Michael Scott 4
4 · Sorrento Therapeutics, Inc. · Filed Jul 20, 2012
Insider Transaction Report
Form 4
Salka Michael Scott
Director
Transactions
- Award
Non-qualified stock options
2012-07-20+15,000→ 15,000 totalExercise: $0.16From: 2013-03-26Exp: 2022-07-20→ Common Stock (15,000 underlying)